Zoono Group Ltd (ASX: ZNO) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Zoono Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Zoono Group Ltd (ASX: ZNO)
Latest News
Share Market News
This ASX biotech share just posted 144% half year revenue growth
Share Market News
Why the Zoono share price rocketed another 25% today
Share Market News
Why this small cap biotech has rocketed 2,511% in the last 5 months
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
04 Sep 2020 | $0.0300 | 0.00% | Final | 21 Sep 2020 |
ZNO ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Zoono Group Ltd
Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products and mould remediation treatments. Geographically, it derives a majority of revenue from Australasia, Asia, United States, India, and also has a presence in United Kingdom and Europe.
ZNO Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
17 Apr 2024 | $0.07 | $-0.01 | -12.35% | 63,329 | $0.08 | $0.08 | $0.06 |
15 Apr 2024 | $0.08 | $0.00 | 0.00% | 34,149 | $0.08 | $0.08 | $0.08 |
11 Apr 2024 | $0.08 | $0.00 | 0.00% | 28,682 | $0.08 | $0.08 | $0.08 |
10 Apr 2024 | $0.08 | $-0.02 | -20.00% | 67,139 | $0.10 | $0.10 | $0.08 |
09 Apr 2024 | $0.10 | $0.03 | 41.86% | 117,690 | $0.09 | $0.10 | $0.09 |
08 Apr 2024 | $0.07 | $0.00 | 0.00% | 65,384 | $0.08 | $0.08 | $0.07 |
05 Apr 2024 | $0.08 | $0.00 | 0.00% | 200,857 | $0.07 | $0.08 | $0.07 |
04 Apr 2024 | $0.07 | $0.00 | 0.00% | 51,909 | $0.08 | $0.08 | $0.07 |
03 Apr 2024 | $0.07 | $0.01 | 16.00% | 381,027 | $0.06 | $0.07 | $0.06 |
02 Apr 2024 | $0.06 | $-0.03 | -32.79% | 931,120 | $0.09 | $0.09 | $0.06 |
28 Mar 2024 | $0.09 | $0.00 | 0.00% | 434,799 | $0.10 | $0.10 | $0.09 |
27 Mar 2024 | $0.10 | $0.01 | 11.41% | 435,975 | $0.10 | $0.10 | $0.09 |
26 Mar 2024 | $0.09 | $0.00 | 0.00% | 1,145,493 | $0.08 | $0.10 | $0.08 |
25 Mar 2024 | $0.08 | $0.00 | 0.00% | 897,271 | $0.09 | $0.10 | $0.08 |
22 Mar 2024 | $0.09 | $0.03 | 49.19% | 1,267,957 | $0.07 | $0.09 | $0.07 |
21 Mar 2024 | $0.06 | $0.00 | 0.00% | 304,535 | $0.06 | $0.06 | $0.06 |
20 Mar 2024 | $0.06 | $0.00 | 0.00% | 314,519 | $0.05 | $0.06 | $0.05 |
19 Mar 2024 | $0.05 | $0.01 | 25.22% | 1,519,138 | $0.04 | $0.06 | $0.04 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
02 Jun 2023 | Donald Clarke | Issued | 22,500 | $1,035 |
Rights issue.
|
02 Jun 2023 | Donald Clarke | Issued | 67,500 | $3,375 |
Rights issue.
|
02 Jun 2023 | Paul Hyslop | Issued | 4,963,168 | $228,305 |
Rights issue.
|
02 Jun 2023 | Elissa Hansen | Issued | 69,000 | $3,450 |
Rights issue.
|
02 Jun 2023 | Elissa Hansen | Issued | 23,000 | $1,058 |
Rights issue.
|
02 Jun 2023 | Paul Hyslop | Issued | 14,889,500 | $744,475 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Donald Ian Clarke | Non-Executive Director | Apr 2017 |
Mr Clarke was a Partner of Minter Ellison's Melbourne Corporate Group, from 1988- 2015. He currently acts as a consultant to them. Don has advised corporate clients on broad corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He can draw on his first-hand experience as a corporate lawyer and a director, of Directors duties and responsibilities and best practice corporate governance, when advising on the legal and practical issues faced at head office and board level. He is Chairman of the Risk Committee.
|
Ms Elissa Hansen | Company SecretaryNon Executive Director | Aug 2015 |
Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She brings governance advice, ensuring compliance with the Listing Rules, Corporations Act, and other relevant legislation. She is member of the Risk Committee.
|
Mr Paul Hyslop | Managing Director | Apr 2017 |
Mr Hyslop founded the Company to address the need for a highly effective, alternative method of combating bacteria and microbes and quickly realized the business opportunity surrounding this technology. Prior to establishing Zoono, Paul was involved in several entrepreneurial ventures ranging from the establishment of a private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002-2005. Paul's experience in business development dates to the 1970s, when he started a personal-care services business after high school, grew it into eight locations and later sold it to his employees. He has also been a commercial flying instructor and Airline pilot, having flown commuter planes for Eagle Air, owned by Air New Zealand.
|
Mr Barry Woolcott | Global General ManagerChief Executive Officer | Mar 2022 |
-
|
Paul Ravlich | Chief Financial Officer |
-
|
|
Lew Mackinnon | Chief Operations Officer |
-
|
|
Barry Woolcott | Global General ManagerChief Executive Officer |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Paul Russell Hyslop and Margaret Jane Morgan and Npt Meg Trustee Limited <Meg A/C> | 74,447,500 | 39.20% |
Citicorp Nominees Pty Limited | 11,247,662 | 5.92% |
Ubs Nominees Pty Ltd | 9,289,905 | 4.89% |
MERRILL LYNCH (AUSTRALIA) NOMINEES PTY LIMITED | 6,322,229 | 3.33% |
Brispot Nominees Pty Ltd <House Head Nominee A/C> | 4,251,197 | 2.24% |
Buttonwood Nominees Pty Ltd | 3,260,660 | 1.72% |
Mr Eelco Wiersma | 2,873,420 | 1.51% |
Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> | 2,265,134 | 1.19% |
National Nominees Limited | 2,062,125 | 1.09% |
Neweconomy Com Au Nominees Pty Limited <900 Account> | 2,021,479 | 1.06% |
Lewis Andrew Craig Mackinnon | 1,700,464 | 0.90% |
Hsbc Custody Nominees (Australia) Limited A/C 2 | 1,398,912 | 0.74% |
Woolcott Investments Limited <The Woolcott Investment A/C> | 1,257,861 | 0.66% |
Hsbc Custody Nominees (Australia) Limited | 938,422 | 0.49% |
Futin Pty Ltd | 881,901 | 0.46% |
Bissapp Software Pty Ltd <Super Fund Account> | 868,200 | 0.45% |
Merrill Lynch (Australia) Nominees Pty Limited <Equity Finance A/C> | 757,588 | 0.40% |
Bnp Paribas Noms Pty Ltd <Drp> | 752,702 | 0.40% |
Bissapp Software Pty Ltd <Bisapp Software Sf A/C> | 630,860 | 0.33% |
Mr David Maher and Mrs Claudia Maher <D & C Maher S/F A/C> | 627,605 | 0.33% |